[ad_1]
9:20
Driven by the news of the new vaccine, Hong Kong shares opened 133 points higher this morning to 26515 points; the H index opened 19 points higher at 10597 points. IBOND (4239) went public this morning, opening 103.
The funds were re-invested in old economic stocks, HSBC (005) increased by 1%; Cathay Pacific (293) was up nearly 3%; between ATMX, Ali alone rose 0.4% to 255 yuan; Tencent (700), Meituan (3690) and Xiaomi (1810) are back by 0.2% and 1% respectively.
8:26
With the three major US stock market indices on the rise, the Hong Kong stock market also rose this morning and got close to 26,500 points.
The good news from the Wuhan pneumonia vaccine prompted the three major US stock indices to rise. In the hope of an economic recovery, travel-related stocks rose, Boeing was up more than 8%; United Airlines also increased by half and Carnival Cruises grew by nearly 10%. Moderna, this time the protagonist of vaccine development, also rose by 9.5%. However, rival Hui Duan fell more than 3%.
The vaccine developed by Moderna this time has a shelf life of 30 days at 2.22-7.78 degrees Celsius. In other words, it doesn’t need to be stored in an ultra-low temperature environment. It lasts for 6 months at minus 20 degrees Celsius. More importantly, the vaccine is compared to Pfizer earlier. Developed vaccines are more effective, reaching nearly 95% As for Pfizer vaccines, the actual rate is around 90%. Moderna will subsequently apply for a manufacturing license from the US Medical Regulatory Agency and is expected to supply 20 million doses of the vaccine to the United States by the end of the year.
The news also pushed European equity markets higher. The German DAX index rose 61 points (0.47%) to 13,138 points; the UK’s FTSE 100 Index rose 104 points (1.66%) to 6421 points; the French CAC index increased by 91 points (1.7%), reported 5471 points.
Oil prices are also expected to rise due to the economic recovery. New York oil futures once rose more than 4% to close at US $ 41.34, or more than 3%. The latest Asian trading hours increase was 0.07% to $ 41.37 per barrel; Brent crude oil in Asia There was a turnaround during trading hours, the latest ratio was $ 43.92 a barrel, down 0.14%. Spot gold recently rose 0.1% to $ 1,890 an ounce.
Starting Tuesday 05:33
There is more good news for Wuhan pneumonia vaccine research and development, which spurred the closure of the three major US stock indices: the Dow Jones Industrial Average and the S&P 500 index hit new highs. The Dow closed at 29,950 points, up 470 points or 1.6%, and the S&P 500 closed at 3,626 points, up 41 points or 1.16%. The Nasdaq Composite Index closed at 11,924 points, up 94 points or 0.8%.
Monday at 11:55 pm
US stocks rose further, with the Dow Jones Industrial Average up 423 points or 1.44%.
In addition, TSMC’s (TSM) production of 5nm and 7nm process chips has been completed and orders are expected in the second half of 2021, according to the Taiwan Economic Daily report. Apple’s four largest customers, Qualcomm, Nvidia and MediaTek have recently increased their orders.
TSMC’s (TSM) stock price topped $ 100 and its latest increase was 7.1% to $ 100.5.
Starting at 22:50
With the hope of Moderna’s strongest vaccine, real economy stocks have been pushed higher again. The Dow recently rose 261 points or 0.9%, and Boeing (BA) and Chevron (CVX) shares rebounded 5% and 3.5% respectively.
Tech stocks were once sold based on vaccine news, but after the market opened, the Nasdaq lost ground and grew nearly 0.5%. However, Zoom, which benefited from the outbreak, recently dropped 3%, while Shopify fell 2.7%.
According to the index, the biggest beneficiaries of vaccines were small stocks: the Russell 2000 index led the market and grew 1.1%.
Starting from 21:00
The vaccine once again pushed the stock market to extremes: the latest Dow futures hit 484 points or 1.65% at 29896 points. However, the technology became the target of the sale of capital and suffered a sharp decline following the announcement of the news of the vaccine: the latest Nasdaq 100 futures fell 0.26%.
The American Society of Modern Biotechnology (MRNA) has announced a preliminary analysis of large-scale clinical trials and announced that its pneumonia vaccine has an effective rate of 94.5%. Moderna and Pfizer (PFE) both use the same mRNA technology, which is the first time it is used in vaccine development.
Shares of MRNA are up nearly 16% to $ 103.6 before the market
According to Moderna, its mRNA-1273 vaccine can be stored in a general household refrigerator for seven days (2 degrees to 8 degrees Celsius) and can be stored at -20 degrees Celsius for up to six months, much better than the a version. -70 degrees of Pfizer.
Moderna preliminary results collected a total of 30,000 participant data. The results included that 90 subjects who took the placebo shovel, Zhong Wufei, compared to just 5 participants who had been vaccinated, and achieved an effective rate of 94.5%. One of the other key findings includes that MRNA vaccines alleviate serious disease.
Moderna said it expects the final analysis to be submitted to the relevant authorities for review at the end of the month, and therefore will require an emergency license.
—————————–
Master the wisdom of financial management and feel the taste of life
The new InvestMAN webpage is here elegantly
—————————–
Distribute your pension to easily gain financial freedom
Click to view “The Book of Retirement Finance”
—————————–
【Global Building Line】 Dream House Zero Distance
Immigration strategy for Hong Kong residents
—————————–
Support Apple’s in-depth report, delve into the community, and kick the mighty – the Like Apple topic and the investigative team’s FB page!
.
[ad_2]
Source link